221 related articles for article (PubMed ID: 30582382)
21. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
[TBL] [Abstract][Full Text] [Related]
22. Near-Infrared Light and pH-Responsive Polypyrrole@Polyacrylic acid/Fluorescent Mesoporous Silica Nanoparticles for Imaging and Chemo-Photothermal Cancer Therapy.
Zhang M; Wang T; Zhang L; Li L; Wang C
Chemistry; 2015 Nov; 21(45):16162-71. PubMed ID: 26494031
[TBL] [Abstract][Full Text] [Related]
23. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
[TBL] [Abstract][Full Text] [Related]
24. Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.
Li H; Zhang JZ; Tang Q; Du M; Hu J; Yang D
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3426-31. PubMed ID: 23706230
[TBL] [Abstract][Full Text] [Related]
25. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
26. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
28. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
29. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
30. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
31. Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release.
Ryplida B; Lee G; In I; Park SY
Biomater Sci; 2019 May; 7(6):2600-2610. PubMed ID: 30984942
[TBL] [Abstract][Full Text] [Related]
32. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.
Danquah M; Fujiwara T; Mahato RI
Biomaterials; 2010 Mar; 31(8):2358-70. PubMed ID: 20018369
[TBL] [Abstract][Full Text] [Related]
33. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
34. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
35. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
36. Micellar delivery of bicalutamide and embelin for treating prostate cancer.
Danquah M; Li F; Duke CB; Miller DD; Mahato RI
Pharm Res; 2009 Sep; 26(9):2081-92. PubMed ID: 19415464
[TBL] [Abstract][Full Text] [Related]
37. [Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program].
Fourcade RO; Richaud P; Coloby P; Malavaud B;
Prog Urol; 2007 Jun; 17(4 Suppl 1):891-910. PubMed ID: 17650746
[No Abstract] [Full Text] [Related]
38. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
[TBL] [Abstract][Full Text] [Related]
39. pH-responsive drug release and real-time fluorescence detection of porous silica nanoparticles.
Zhang X; Wang Y; Zhao Y; Sun L
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():19-26. PubMed ID: 28532020
[TBL] [Abstract][Full Text] [Related]
40. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
